| Financial Year |
March 31 2023 |
| Monetary Funds |
611,702,269.75 |
| Held-for-trading Financial Assets |
32,500,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
60,275,269.73 |
| Advances to Suppliers |
4,934,337.19 |
| Other Receivables |
50,834,405.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
976,362.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
17,001,378.76 |
| Other Current Assets |
18,409,091.41 |
| Total Current Assets |
796,633,114.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
230,803,903.85 |
| Long-term Equity Investment |
6,400,050.05 |
| Investment Properties |
-- |
| Fixed Assetes |
7,638,105.83 |
| Under-construction Projects |
37,929,454.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
62,265,425.90 |
| R&D expenses |
-- |
| Goodwill |
108,766,759.30 |
| Long-Term Deferred and Prepaid Expenses |
125,973,011.03 |
| Deferred Income Tax Assets |
51,285,223.42 |
| Other Non-Current Assets |
1,755,362.92 |
| Sub-Total of Non-Current Assets |
1,365,071,326.14 |
| Total Assets |
2,161,704,441.07 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
23,368,994.26 |
| Accounts Received In Advance |
3,775,369.41 |
| Employee Compensation Payable |
7,532,587.21 |
| Taxes Payable |
8,405,506.70 |
| Interest Payable |
19,601.42 |
| Dividend Payable |
-- |
| Other payables |
61,884,800.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
97,451,111.53 |
| Other Current Liabilities |
635,851.68 |
| Sub-Total of Current Liabilities |
242,133,869.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,544,160.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
953,873,077.75 |
| Total Liabilities |
1,196,006,947.29 |
| Paid-In Capital(Or Share Stock) |
129,634,031.00 |
| Capital Surplus |
635,884,293.64 |
| Surplus Reserve |
30,856,579.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
181,060,296.95 |
| Minority Stockholder's Interest |
-11,737,707.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
977,435,200.93 |
| Owner's Equity（Stockholder's Equity） |
965,697,493.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,161,704,441.07 |
